Black Diamond Therapeutics is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.

Biotechnology

Education

Black Diamond Therapeutics

Black Diamond Therapeutics' headquarters in Cambridge, MA, United States

Melanie Morrison

Elizabeth Buck

Brent Hatzis-Schoch

Elizabeth L. Montgomery

Sergey Yurasov

Erika Jones

Tai-An Lin

Etienne Dardenne

Ali Behbahani

Rajeev Shah

Garry E. Menzel

Paul Workman

Alexander Mayweg

Mark A. Velleca

Kapil Dhingra

Samarth Kulkarni

George Trainor

Wendy Dixon

Leadership Team

Finance and Legal

Research and Development

Black Diamond Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Finance and Legal

Research and Development

Offices

Similar companies